Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Lysophospholipid variants in hepatocellular carcinoma.

Skill NJ, Jianmin W, Yan X, Zhao Z, Tector AJ, Maluccio MA.

J Surg Res. 2013 Jun 15;182(2):241-9. doi: 10.1016/j.jss.2012.10.037. Epub 2012 Nov 8.

PMID:
23158405
2.

Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.

Lou L, Chen YX, Jin L, Li X, Tao X, Zhu J, Chen X, Wu S, Ye W, He J, Ding G.

J Int Med Res. 2013 Feb;41(1):55-63. doi: 10.1177/0300060512474124. Epub 2013 Jan 23.

PMID:
23569130
3.

Implications of the lysophosphatidic acid signaling axis in liver cancer.

Lopane C, Agosti P, Gigante I, Sabbà C, Mazzocca A.

Biochim Biophys Acta. 2017 Aug;1868(1):277-282. doi: 10.1016/j.bbcan.2017.06.002. Epub 2017 Jun 4. Review.

PMID:
28591560
4.

Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.

Sokolov E, Eheim AL, Ahrens WA, Walling TL, Swet JH, McMillan MT, Simo KA, Thompson KJ, Sindram D, McKillop IH.

J Surg Res. 2013 Mar;180(1):104-13. doi: 10.1016/j.jss.2012.10.054. Epub 2012 Nov 15.

PMID:
23182454
5.

Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma.

Wu JM, Xu Y, Skill NJ, Sheng H, Zhao Z, Yu M, Saxena R, Maluccio MA.

Mol Cancer. 2010 Mar 31;9:71. doi: 10.1186/1476-4598-9-71.

6.

Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.

Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, Kim JM, Lee JS, Kang J, Park CG, Mills GB, Lee HY.

Oncogene. 2011 Mar 17;30(11):1351-9. doi: 10.1038/onc.2010.517. Epub 2010 Nov 22.

PMID:
21102517
7.

Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels.

Enooku K, Uranbileg B, Ikeda H, Kurano M, Sato M, Kudo H, Maki H, Koike K, Hasegawa K, Kokudo N, Yatomi Y.

PLoS One. 2016 Sep 1;11(9):e0161825. doi: 10.1371/journal.pone.0161825. eCollection 2016.

8.

Hepatocellular carcinoma associated lipid metabolism reprogramming.

Skill NJ, Scott RE, Wu J, Maluccio MA.

J Surg Res. 2011 Jul;169(1):51-6. doi: 10.1016/j.jss.2009.09.005. Epub 2009 Sep 25.

PMID:
19932908
9.

Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.

Wu JM, Skill NJ, Maluccio MA.

HPB (Oxford). 2010 Nov;12(9):625-36. doi: 10.1111/j.1477-2574.2010.00207.x.

10.

Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.

Wright JH, Johnson MM, Shimizu-Albergine M, Bauer RL, Hayes BJ, Surapisitchat J, Hudkins KL, Riehle KJ, Johnson SC, Yeh MM, Bammler TK, Beyer RP, Gilbertson DG, Alpers CE, Fausto N, Campbell JS.

Int J Cancer. 2014 Feb 15;134(4):778-88. doi: 10.1002/ijc.28421. Epub 2013 Sep 16.

11.

Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.

Mazzocca A, Dituri F, Lupo L, Quaranta M, Antonaci S, Giannelli G.

Hepatology. 2011 Sep 2;54(3):920-30. doi: 10.1002/hep.24485. Epub 2011 Aug 8.

PMID:
21674557
12.

Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.

Zhu B, Shi S, Ma YG, Fan F, Yao ZZ.

Hepatogastroenterology. 2012 May;59(115):785-9. doi: 10.5754/hge11427.

PMID:
22020916
13.

Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.

Skill N, Wu J, Xu Y, Zhao Z, Maluccio M.

Cancer Invest. 2013 Feb;31(2):145-55. doi: 10.3109/07357907.2012.762779.

PMID:
23362952
14.

[Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].

Chang X, Wang L, Zang M, Rong W, Wu Z, Liu L, Du J, Liu J, Wu J, Qu C.

Zhonghua Zhong Liu Za Zhi. 2015 Jan;37(1):5-10. Chinese.

PMID:
25877311
15.

Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.

David M, Sahay D, Mege F, Descotes F, Leblanc R, Ribeiro J, Clézardin P, Peyruchaud O.

PLoS One. 2014 May 14;9(5):e97771. doi: 10.1371/journal.pone.0097771. eCollection 2014.

16.

Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.

Pais R, Lebray P, Rousseau G, Charlotte F, Esselma G, Savier E, Thabut D, Rudler M, Eyraud D, Vezinet C, Siksik JM, Vaillant JC, Hannoun L, Poynard T, Ratziu V.

Clin Gastroenterol Hepatol. 2015 May;13(5):992-9.e2. doi: 10.1016/j.cgh.2014.10.011. Epub 2014 Oct 20.

PMID:
25459558
17.

Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study.

Chun YS, Huang M, Rink L, Von Mehren M.

World J Surg Oncol. 2014 Jul 22;12:231. doi: 10.1186/1477-7819-12-231.

18.

Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.

Benbow JH, Thompson KJ, Cope HL, Brandon-Warner E, Culberson CR, Bossi KL, Li T, Russo MW, Gersin KS, McKillop IH, deLemos AS, Schrum LW.

Am J Pathol. 2016 Jan;186(1):145-58. doi: 10.1016/j.ajpath.2015.09.015. Epub 2015 Nov 18.

PMID:
26603137
19.

Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients.

Jain D, Nayak NC, Saigal S.

Eur J Gastroenterol Hepatol. 2012 Jul;24(7):840-8. doi: 10.1097/MEG.0b013e3283534b40.

PMID:
22495397
20.

The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.

Nischalke HD, Berger C, Luda C, Berg T, Müller T, Grünhage F, Lammert F, Coenen M, Krämer B, Körner C, Vidovic N, Oldenburg J, Nattermann J, Sauerbruch T, Spengler U.

PLoS One. 2011;6(11):e27087. doi: 10.1371/journal.pone.0027087. Epub 2011 Nov 7.

Supplemental Content

Support Center